The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.

1. The in vitro and in vivo pharmacology of GR203040 ((2S, 3S)-2-methoxy-5-tetrazol-1-yl-benzyl-(2-phenyl-piperidin-3-y l)-amine), a novel, highly potent and selective non-peptide tachykinin NK1 receptor antagonist, was investigated in the present study. 2. GR203040 potently inhibited [3H]-substance...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Beattie, D. T., Beresford, I. J., Connor, H. E., Marshall, F. H., Hawcock, A. B., Hagan, R. M., Bowers, J., Birch, P. J., Ward, P.
Formato: Artigo
Idioma:Inglês
Publicado em: 1995
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1909174/
https://ncbi.nlm.nih.gov/pubmed/8719789
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados